Pharmafile Logo

Biogen targets ‘lost to follow-up’ patients in MS campaign

Biotech company's 1MSg initiative will provide a range of educational materials

Biogen 1MSg campaign

Biogen has launched a new campaign to highlight concerns over the lack of patient engagement with specialist services for multiple sclerosis.

The 1MSg educational initiative offers video advice, an educational website and will see educational materials delivered to GP surgeries and MS centres across the country to help spread the campaign message.

The biotech’s 1MSg messaging centres on survey data showing 93% of healthcare professionals with expertise in MS believe that there are people with the condition who are missing out on MS services.

The survey involved around 100 neurologists and nurses and was conducted by Opinion Health on behalf of Biogen.

The poll also found that 97% of those surveyed think there are people who could benefit from reconsidering how they manage their disease in light of how the MS landscape has and continues to evolve.

The campaign, which has a core message of ‘take control, know your choices’, aims to highlight the benefits of regular and quality engagement with MS-specialists in order to ensure people are making informed decisions about their disease-management.

Dr Martin Duddy is a consultant neurologist specialising in MS and one of a panel of 1MSg clinical experts.

He said: “We know there are a significant number of people with MS who have lost touch with their specialist support team. The danger is that they may be missing out on treatments and care that could help to change the trajectory of their disease, preventing relapses and slowing down progression and disability.

“I want to encourage all people living with MS to regularly see a member of their local MS team.”

Dominic Tyer
18th February 2016
From: Marketing
Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links